MEDXtractor Corp. (
CSE.MXT,
OTCMKTS: MXTTF,
Forum) has reported that it has acquired all rights to United States Provisional Patent application number 63132186, "Novel Method of Generating Credible Solutions from Non-validated Datasets".
The Application was created by MXT President Jim Durward and was accepted for filing by the United States Patent Office on December 30, 2020. A full patent application is being prepared and will be filed in due course. Conditions of the transfer include MXT's payment of all patent-associated and commercialization expenses and MXT's continued pursuance of the Application processes.
President Jim Durward commented:
"There has been significant activity in intellectual property developments related to digital diagnosis in the health sector and as recently as March 31, 2021 Mind Cure Health ("MCUR" - CSE) filed a provisional patent related to its iSTRYM digital therapeutics application. It became apparent to me that foundational infrastructure was not being adequately addressed and will be a prime application in the future. Based on my extensive experience in data conditioning, analysis and pattern recognition, a provisional patent application was filed with the US Patent Office on December 30, 2020. Today, for the benefit of all MXT shareholders, I have agreed to transfer all rights to this Application to MXT for the sum of $1.00".
Full story
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.
FULL DISCLOSURE: Medxtractor Corp. is a client of Stockhouse Publishing.